Posts Tagged :

Specialty Pharmacy Trends

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions 70 70 Shields Health Solutions

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions

Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation 216 115 Shields Health Solutions

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation

This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients

This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services 204 115 Shields Health Solutions

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services
Shields and UnityPoint at Home have expanded their partnership providing patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, broaden treatment options, enhance medication management, and improve overall health.